CA2616844A1 - Creatine-fatty acids - Google Patents

Creatine-fatty acids Download PDF

Info

Publication number
CA2616844A1
CA2616844A1 CA002616844A CA2616844A CA2616844A1 CA 2616844 A1 CA2616844 A1 CA 2616844A1 CA 002616844 A CA002616844 A CA 002616844A CA 2616844 A CA2616844 A CA 2616844A CA 2616844 A1 CA2616844 A1 CA 2616844A1
Authority
CA
Canada
Prior art keywords
creatine
fatty acid
compounds
fatty acids
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002616844A
Other languages
French (fr)
Other versions
CA2616844C (en
Inventor
Shan Chaudhuri
Joseph Macdougall
Jason Peters
James Ramsbottom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Innovations Holding Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2616844A1 publication Critical patent/CA2616844A1/en
Application granted granted Critical
Publication of CA2616844C publication Critical patent/CA2616844C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention describes compounds produced from a creatine molecule and a fatty acid molecule. The compounds being in the form of creatine-fatty acid compounds being bound by an anhydride linkage, or mixtures thereof made by reacting creatine or derivatives thereof with an appropriate fatty acid previously reacted with a thionyl halide. The administration of such molecules provides supplemental creatine with enhanced bioavailability and the additional benefits conferred by the specific fatty acid.
CA002616844A 2007-02-20 2007-02-20 Creatine-fatty acids Expired - Fee Related CA2616844C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002577439A CA2577439C (en) 2007-02-20 2007-02-20 Creatine-fatty acids

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002577439A Division CA2577439C (en) 2007-02-20 2007-02-20 Creatine-fatty acids

Publications (2)

Publication Number Publication Date
CA2616844A1 true CA2616844A1 (en) 2007-05-07
CA2616844C CA2616844C (en) 2009-10-27

Family

ID=38024518

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002616844A Expired - Fee Related CA2616844C (en) 2007-02-20 2007-02-20 Creatine-fatty acids
CA002577439A Expired - Fee Related CA2577439C (en) 2007-02-20 2007-02-20 Creatine-fatty acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002577439A Expired - Fee Related CA2577439C (en) 2007-02-20 2007-02-20 Creatine-fatty acids

Country Status (1)

Country Link
CA (2) CA2616844C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7511162B2 (en) 2007-02-20 2009-03-31 Multi Formulations Ltd. Preparation of amino acid-fatty acid anhydrides
US7319157B1 (en) 2007-02-20 2008-01-15 Multi Formulations Ltd. Creatine-fatty acids
US7314945B1 (en) 2007-02-20 2008-01-01 Multi Formulations Ltd. Creatine-fatty acids
WO2008138090A1 (en) * 2007-05-10 2008-11-20 Multi Formulations Ltd. Preparation of amino acid-fatty acid anhydrides
AU2007362563A1 (en) * 2007-12-18 2009-06-25 Northern Innovations And Formulations Corp. Creatinol-fatty acid esters

Also Published As

Publication number Publication date
CA2577439C (en) 2008-04-08
CA2577439A1 (en) 2007-05-07
CA2616844C (en) 2009-10-27

Similar Documents

Publication Publication Date Title
CA2616844A1 (en) Creatine-fatty acids
WO2009067686A8 (en) Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
WO2006124737A3 (en) Molecular constructs suitable for targeted conjugates
Rakesh et al. Quinazolinones linked amino acids derivatives as a new class of promising antimicrobial, antioxidant and anti-inflammatory agents
EP2889624A3 (en) Reversible covalent linkage of functional molecules
EP2374481A3 (en) Novel reagents and method for conjugating biological molecules
WO2009011855A3 (en) Selection of nucleic acid-based sensor domains within nucleic acid switch platform
WO2006096207A3 (en) Methods for preparing multivalent constructs for therapeutic and diagnostic applications
WO2007101551A3 (en) Phospholipid complexes of curcumin having improved bioavailability
AU2006236578A1 (en) The use of alkenyl succinic anhydride compounds derived from symmetrical olefins in internal sizing for paper production
WO2006002895A3 (en) Conjugates of antibody and duoarmycin derivatives as antitumor agents
WO2007070562A3 (en) Non-hygroscopic compositions of enterostatin
EP2386861A3 (en) Cross-ß structure binding compounds
EP3037401A3 (en) 14-hydroxy-docosahexaenoic acid compounds
TW200613270A (en) Ionic liquids having fluoroalkyltrifluoroborate anions
AU2001246623A1 (en) Molecule of pharmaceutical interest comprising at its N-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid
ATE452625T1 (en) SUPERLOADED LIPOSOMES FOR DRUG DELIVERY
WO2007002128A3 (en) Compositions comprising and processes for producing inorganic salts of hop acids
WO2006006196A3 (en) Synthesis of organometallic molecules that can be used as markers of organic substances
ZA200703983B (en) N-heterocyclyl phthalic acid diamides as insecticides
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
IL212603A (en) Combination comprising a thioester and at least one esterase inhibitor, a process for increasing the bioavailability of the thioester by such combination, a pharmaceutical composition comprising said combination and kit comprising it
EP1852421A4 (en) Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof
CA2577437A1 (en) Creatine-fatty acids
EP1903050A3 (en) A process for the preparation of cholanic acids

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220221

MKLA Lapsed

Effective date: 20220221